Coastlands Capital LP 4

What Happened Coastlands Capital LP, listed as a 10% owner of Pasithea Therapeutics Corp. (KTTA), reported an open-market/private purchase of 100,000 shares on 2026-06-17 at $0.53 per share, for a total of approximately $53,000. This was a purchase (accumulation) by an institutional holder rather than a corporate officer or director.

Key Details

• Transaction date and price: 2026-06-17 — 100,000 shares @ $0.53 each (total ~$53,000).
• Filing date: Form 4 filed 2026-06-22 (five days after the reported transaction). Form 4s are typically due within two business days, so this filing appears later than the usual reporting window.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: The filing clarifies that Coastlands Capital LP and related entities (Coastlands Capital GP LLC, Coastlands Capital LLC) are investment adviser/general partner entities and that Matthew Perry is the control person. The reporting persons filed jointly but disclaim membership in a group and disclaim beneficial ownership except to the extent of pecuniary interest.

Context

• This is an institutional purchase by a 10% owner, which reflects the activity of an investment firm rather than insider trading by company management. Such purchases can indicate the firm is adding to a position but do not by themselves reveal motivation.
• No options, awards, gifts, or tax-withholding codes are involved in this transaction.